Skip to main content
. 2013 Oct 4;7:1007–1023. doi: 10.2147/PPA.S51299

Table 3.

Analyzed population: all insulin users versus all users of bitherapy or tritherapy

All insulin users n = 270
All bi- or tritherapy users n = 443
P-value
n % n %
Age (mean, SD) 59.14 10.86 60.27 9.32 0.1554
 Age at diagnosis 44.6 11.95 49.53 10.39 <0.0001
 Age at insulin initiation 51.61 13.03 N/A
 Years diagnosed 14.66 9.88 10.75 7.61 <0.0001
Sex
 Male 166 61.48% 310 69.98% 0.0213
 Female 104 38.52% 133 30.02% 0.0213
Currently employed 76 28.15% 121 27.31% 0.8096
Household income
 <20,000€ 88 32.59% 97 21.90% 0.0021
 20,000€ to <50,000€ 138 51.11% 233 52.60% 0.7006
 50,000€ or more 22 8.15% 65 14.67% 0.0061
 Decline to answer 22 8.15% 48 10.84% 0.2281
College education 66 24.44% 148 33.41% 0.0096
BMI
 Underweight 0 0.00% 1 0.23% N/A
 Normal weight 40 14.81% 45 10.16% 0.0735
 Overweight 86 31.85% 177 39.95% 0.0277
 Obese 135 50.00% 209 47.18% 0.4651
 Decline to answer 9 3.33% 11 2.48% 0.5197
Health behaviors
 Currently drink 190 70.37% 336 75.85% 0.1126
 Currently smoke 47 17.41% 75 16.93% 0.8701
 Regularly exercise 141 52.22% 238 53.72% 0.697
Charlson comorbidity index (mean, SD) 0.6 1.33 0.33 0.69 0.0017
Comorbidities
 Depression 36 13.33% 50 11.29% 0.4242
 Myocardial infarction 23 8.52% 20 4.51% 0.0422
 Stroke 12 4.44% 10 2.26% 0.1294
 TIA 4 1.48% 2 0.45% 0.1995
 Congestive heart failure 8 2.96% 7 1.58% 0.246
 Hypertension 111 41.11% 205 46.28% 0.1771
 Angina 27 10.00% 50 11.29% 0.5869
 Arrhythmia 13 4.81% 31 7.00% 0.2208
Prescribing physician
 PCP 53 19.63% 334 75.40% <0.0001
 Endocrinologist/diabetologist 210 77.78% 107 24.15% <0.0001
 Nurse practitioner/physician assistant 0 0.00% 0 0.00% N/A
 Other 7 2.59% 2 0.45% 0.0361
Agree/strongly agree to being afraid of needles 24 8.89% 47 10.61% 0.4485
Microvascular complications
 Macular edema 43 15.93% 14 3.16% <0.0001
 Neuropathic pain 53 19.63% 33 7.45% <0.0001
 Kidney damage 28 10.37% 11 2.48% <0001
 End organ damage (2010, 2011 only) 14 7.61% 5 1.55% 0.0038
 Foot ulcer 14 5.19% 16 3.61% 0.3305
At least one microvascular complication 104 38.52% 64 14.45% <0.0001
At least one complication (TIA, stroke, HA or microvascular complication) 119 44.07% 83 18.74% <0.0001
HbA1c (%)
 HbA1c >7 89 32.96% 78 17.61% <0.0001
 HbA1c (missing) 94 34.81% 228 51.47% <0.0001
Fasting glucose (mg/dl)
 Fasting glucose >130 42 15.56% 45 10.16% 0.0409
 Fasting glucose (missing) 152 56.30% 311 70.20% 0.0002
Satisfaction with treatment
 Very/extremely satisfied with treatment 149 55.60% 227 51.24% 0.2592
 Very/extremely dissatisfied with treatment 40 14.93% 51 11.51% 0.1991
Morisky adherence* (2010, 2011 only)
 Compliant (MMAs = 0) 152 82.61% 233 72.36% 0.0066
 Forget to take medication 25 13.59% 80 24.84% 0.0014
 Careless about medication 12 6.52% 36 11.18% 0.0667
 Stop when feeling better 1 0.54% 5 1.55% 0.2508
 Stop when feeling worse 5 2.72% 16 4.97% 0.1876

Notes:

*

Assessed using the MMAS. The MMAS includes four items (“do you ever forget to take your medicine?”; “are you careless at times about taking your medicine?”; “when you feel better do you sometimes stop taking your medicine?”; and “sometimes if you feel worse when you take your medicine, do you stop taking it?”). All items have a dichotomous yes/no response scale and are summed to form a total score (which varies from 0 to 4, with lower scores indicating greater adherence).

Abbreviations: BMI, body mass index; MMAS, Morisky Medication Adherence Scale; SD, standard deviation; HA, heart attack; TIA, transient ischemic attack; PCP, primary care physician.